Introduction {#Sec1}
============

The number of bariatric procedures is increasing annually. According to the 2016 International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) survey data from 58/62 IFSO Societies, the total number of bariatric/metabolic procedures performed in 2016 was 685,874. The most common primary surgical bariatric/metabolic procedure was laparoscopic sleeve gastrectomy (LSG) (340,550; 53.6%), followed by Roux-en-Y gastric bypass (LRYGB) (191,326; 30.1%), and one-anastomosis gastric bypass (OAGB) (30,563; 4.8%) \[[@CR1], [@CR2]\]. While the benefits of bariatric surgery are unquestionable, namely, weight loss and remission of comorbidities, surgeons must consider the risk of complications, especially because bariatric surgery is an elective procedure. The perioperative morbidity for all Clavien--Dindo complication grades after bariatric surgery is relatively low at 10.1%, with treatment according to the Enhanced Recovery After Bariatric Surgery (ERABS) protocol \[[@CR3]\]. Once complications occur, they are an issue for both the patient and the surgeon. Length of hospital stay (LOS) after bariatric surgery is ≤ 3 days, which limits close patient monitoring postoperatively \[[@CR4]\]. Therefore, it is particularly important to identify specific markers for early detection of complications. In centers with implemented ERAS and ERABS protocols, discharges from hospital usually occur at postoperative day (POD) 2, sometimes at POD 1 \[[@CR3], [@CR5]\]. The goal of this study was to find early markers, even nonspecific, i.e., without highest sensitivity and specificity possible. Those markers would indicate patients, who potentially develop perioperative morbidity and who should have more attention and probably should stay longer at hospital. Inflammatory marker measurement may achieve this goal and has met similar targets in several surgical fields \[[@CR6]--[@CR10]\]. We aimed to determine the correlations between C-reactive protein (CRP) and white blood count (WBC), both measured routinely on the first POD, and perioperative morbidity in the first 30 days after LSG, OAGB, and LRYGB.

Materials and Methods {#Sec2}
=====================

Methods {#Sec3}
-------

This was a retrospective cohort study analyzing data for patients who underwent surgical treatment for morbid obesity in seven referral bariatric centers from February 2014 to March 2018. Each participating center provided specific data, which were processed and used in the overall analysis. The study was designed and performed according to the STROBE guidelines for observational studies \[[@CR11]\]. The included patients underwent LSG, LRYGB, or OAGB, which are the most commonly performed bariatric procedures in these centers. Exclusion criteria were revision surgeries; bariatric operations other than LSG, LRYGB, or OAGB; extended surgeries during which other procedures were performed; and lack of necessary data or patients lost to follow-up. All bariatric operations in the participating centers were performed laparoscopically using comparable surgical techniques, and perioperative care was performed according to enhanced recovery after surgery protocols (ERAS® \[[@CR3], [@CR5], [@CR12]\]), which ensured reliable data comparison. Part of our study was a review of the medical records from the databases of the participating centers. Baseline patients' characteristics were sex, age, body mass index, relevant comorbidities, and the bariatric procedure.

The primary endpoint was determining the usefulness of routinely tested inflammatory markers on POD 1, i.e., CRP and WBC, to predict postoperative morbidity after LSG, LRYGB, and OAGB.

Patients were divided into two groups: a complicated group constituting patients with postoperative complications, and a non-complicated group constituting patients without postoperative complications. Additionally, patients' data were analyzed separately for LSG and gastric bypass (LRYGB and OAGB).

We defined postoperative morbidity as any deviation from the standard postoperative course requiring additional adequate treatment measures within 30 days of the initial procedure classified according to the Clavien--Dindo grading system \[[@CR13]\]. LOS was defined as the period from surgery to discharge. Prolonged LOS was defined as \> 4 days because, depending on the treatment protocols in participating centers, planned hospitalization time for bariatric surgery was 3 or 4 days. Readmissions were analyzed only if they occurred in the index hospitals.

CRP and WBC were measured at each participating center on POD 1 in hospital laboratories with ISO 9001 certificates, using comparable laboratory methods. CRP was measured in blood serum using an immunonephelometric technique, and WBC was measured in full blood samples preserved with ethylenediaminetetraacetic acid, using flow cytometry.

Statistical Analysis {#Sec4}
--------------------

Statistical analyses were performed using Statistica 13.5 software (StatSoft®, Tulsa, OK). Continuous values were presented as means with standard deviations or medians with interquartile ranges, as appropriate. Quantitative variables were compared using Student's *t* test or the Mann--Whitney *U* test, while qualitative variables were compared with the chi-squared test with or without Yates' correction. Optimal cut-off points for laboratory parameters were chosen using Youden's index. Multivariate logistic regression models adjusted for relevant intergroup baseline differences were performed to calculate odds ratios (ORs) with 95% confidence intervals (CIs). *P* values ≤ 0.05 were considered statistically significant.

Study Group {#Sec5}
-----------

The study group constituted 1400 patients from seven bariatric centers with complete data for a 30-day postoperative follow-up. Figure [1](#Fig1){ref-type="fig"} is a patient flow chart. There were 929 women (66%) and 471 men (34%) in the study group, with a median age of 42 years (range, 35--51 years); 1192 patients underwent LSG (85%), 120 underwent LRYGB (9%), and 80 underwent OAGB (6%).Fig. 1Flow chart of patients through the study

Results {#Sec6}
=======

Group Characteristics {#Sec7}
---------------------

Perioperative morbidity was encountered in 69 patients (4.93%), and morbidity rates differed significantly between LSG and bypass surgery (*p* \< 0.001). Mortality was 0.29% (four patients). The general characteristics of the study groups and differences in perioperative laboratory results are presented in Table [1](#Tab1){ref-type="table"}.Table 1General characteristics patients after LSG or LRYGB and OAGBComplicatedNon-complicatedp valueLSG  *n* (%)47 (3.94%)1145 (96.06%)n/a  Males/females, *n* (%)14/33 (30%/70%)402/743 (35%/65%)0.453  Median age, years (IQR)40 (35--49)41 (34--50)0.944  Median BMI, kg/m^2^ (IQR)44.46 (39.31--49.84)43.59 (40.27--48)0.435  Diabetes mellitus type 2, *n* (%)13 (27.66%)251 (21.96%)0.357  Arterial hypertension, *n* (%)28 (59.57%)575 (50.22%)0.211  Obstructive sleep apnea, *n* (%)7 (14.89%)147 (12.84%)0.637  Median operative time, min (IQR)75 (60--105)70 (55.5--90)0.113  Median LOS, days (IQR)5 (4--7)3 (3--4)\< 0.001  Readmissions, *n* (%)12 (25.53%)9 (0.79%)\< 0.001  Median CRP on POD 1, mg/L (IQR)28.77 (15.1--48.8)18.84 (11.6--29.6)0.002  Median WBC on POD 1, × 10^3^/μL (IQR)12.42 (10.7--16.83)11.16 (9.25--13.21)0.002Bypasses  *n* (%)22 (10.58%)186 (89.42%)n/a  Males/females, *n* (%)9/13 (41%/59%)46/140 (25%/75%)0.088  Median age, years (IQR)44 (40--50)46 (39--54)0.188  Median BMI, kg/m^2^ (IQR)42.05 (37--46.60)42.05 (38.30--46.66)0.857  Diabetes mellitus type 2, *n* (%)11 (50.0%)42 (22.58%)*0.022*  Arterial hypertension, *n* (%)14 (63.64%)112 (60.22%)0.756  Obstructive sleep apnea, *n* (%)4 (18.18%)34 (18.28%)0.965  Median operative time, min (IQR)95 (65--150)95 (65--150)0.810  Median LOS, days (IQR)4 (4--8)3 (2--4)*0.003*  Readmissions, *n* (%)7 (31.82%)5 (2.69%)\< 0.001  Median CRP on POD 1, mg/L (IQR)13.51 (6.7--27.76)18.68 (10--41.1)0.316  Median WBC on POD 1, × 10^3^/μL (IQR)15.69 (13.88--16.78)11.28 (9.47--13.23)\< 0.001*BMI*, body mass index; *IQR*, interquartile range; *LOS*, length of hospital stay; *CRP*, C-reactive protein; *WBC*, white blood count; *POD*, postoperative day

Main Outcomes {#Sec8}
-------------

Perioperative morbidity data after LSG and bypass surgery are presented in Table [2](#Tab2){ref-type="table"}.Table 2Perioperative morbidity sorted out regarding Clavien--Dindo classification of surgical complicationsC--DPerioperativeLSGLRYGB and OAGBVUrosepsis10GI leak10Intra-abdominal hernia, GI leak01Acute pancreatitis, GI leak, peritonitis10IVbAcute respiratory failure10IVaHeart failure10IIIbSubphrenic abscess21GI leak53Postoperative bleeding (reoperation)113GI stricture02IIIaGI stricture11Postoperative bleeding (treated endoscopically)47Surgical site infection31Intraperitoneal fluid collection10Subphrenic hematoma, acute pancreatitis10IIPostoperative bleeding (treated with blood transfusions)23Renal insufficiency10*Clostridium difficile* infection10Superior mesenteric vein and/or portal vein thrombosis20Pneumonia20IVomiting/dehydration61Total47 (3.94%)22 (10.58%)

Regarding the cut-off points for CRP and WBC for perioperative complications, we determined these separately for LSG and bypass surgery. We were able to determine the cut-off points for all analyzed inflammatory markers for LSG for general morbidity and morbidity of III--V Clavien--Dindo grades; however, for LRYGB and OAGB, we were able to determine a significant cut-off for only WBC on POD 1 (Table [3](#Tab3){ref-type="table"}).Table 3Results of ROC analyses of CRP on POD 1 (mg/L) and WBC on POD 1 (× 10^3^/μL) for LSG and bypassesCut-off pointAUC (95% CI)p valueSensitivity (%)Specificity (%)LSG  MorbidityCRP33.320.66 (0.56--0.76)0.00247.180.2WBC12.150.65 (0.56--0.74)0.00148.766.9  Morbidity of III--V Clavien--DindoCRP35.000.59 (0.46--0.72)0.04836.481.5WBC12.200.69 (0.58--0.579)0.00166.763.3Bypasses  MorbidityCRP82.750.42 (0.26--0.58)0.332n/an/aWBC13.780.8 (0.69--0.90)\< 0.00181.879.6  Morbidity of III--V Clavien--DindoCRP92.70.47 (0.25--0.69)0.778n/an/aWBC13.780.79 (0.66--0.92)\< 0.00185.777.3

The cut-off points and other possible risk factors for perioperative morbidity after LSG were analyzed in logistic regression models and are presented in Table [4](#Tab4){ref-type="table"}. Factors that were significant in the univariate logistic regression models were selected for multivariate analyses. CRP \> 33.32 mg/L and WBC \> 12.15 × 10^3^/μL on POD 1, and longer operating time with LSG, were prognostic factors for LSG-related morbidity (Table [4](#Tab4){ref-type="table"}).Table 4Logistic regression models of risk factors for perioperative morbidity after LSGOR95% CI*p* valueUnivariate  Females1.130.82--1.550.454  Age, every year1.000.97--1.030.975  BMI, every kg/m^2^1.020.98--1.070.268  Diabetes mellitus type 21.170.84--1.620.358  Arterial hypertension1.210.90--1.630.213  Obstructive sleep apnea1.100.73--1.670.638  Operative time, every min1.011.00--1.020.034  CRP on POD 1 \> 33.32 mg/L3.191.57--6.490.001  WBC on POD 1 \> 12.15 × 10^3^/μL2.201.15--4.210.018Multivariate  Operative time, every min1.021.00--1.030.016  CRP on POD 1 \> 33.32 mg/L2.271.02--5.020.043  WBC on POD 1 \> 12.15 × 10^3^/μL3.341.54--7.250.002*OR*, odds ratio; *95% CI*, 95% confidence interval; *BMI*, body mass index; *CRP*, C-reactive protein; *WBC*, white blood count; *POD*, postoperative day

Then, the same analyses were created for perioperative morbidity of III--V Clavien--Dindo grades after LSG. WBC on POD 1 \> 12.2 × 10^3^/μL, determined in the ROC analysis was the only significant risk factor for perioperative morbidity of III--V Clavien--Dindo grades after LSG (Table [5](#Tab5){ref-type="table"}).Table 5Logistic regression models of risk factors for perioperative morbidity of III--V Clavien--Dindo after LSGOR95% CI*p* valueUnivariate  Females1.070.49--2.360.859  Age, every year0.990.96--1.030.714  BMI, every kg/m^2^1.020.97--1.070.449  Diabetes mellitus type 21.070.45--2.540.879  Arterial hypertension1.120.54--2.320.765  Obstructive sleep apnea0.640.22--2.490.629  Operative time, every min1.011.00--1.020.080  CRP on POD 1 \> 35 mg/L2.060.82--5.180.126  WBC on POD 1 \> 12.2 × 10^3^/μL2.871.24--6.650.014*OR*, odds ratio; *95% CI*, 95% confidence interval; *BMI*, body mass index; *CRP*, C-reactive protein; *WBC*, white blood count; *POD*, postoperative day

We analyzed the cut-off points and other possible risk factors for perioperative morbidity after LRYGB and OAGB using logistic regression models, and results are presented in Table [5](#Tab5){ref-type="table"}. In the univariate analyses, type 2 diabetes and WBC on POD 1 were significant risk factors. We found that type 2 diabetes and WBC \> 13.78 × 10^3^/μL on POD 1 indicated significantly increased risk for perioperative complications after LRYGB and OAGB (Table [6](#Tab6){ref-type="table"}).Table 6Logistic regression models of risk factors for postoperative morbidity after bypassesOR95% CI*p* valueUnivariate  Females0.480.19--1.180.110  Age0.970.93--1.020.190  BMI1.000.94--1.070.913  Diabetes mellitus type 23.231.12--9.090.029  Arterial hypertension1.160.46--2.890.756  Obstructive sleep apnea1.030.28--3.860.965  Operative time1.000.99--1.010.855  CRP on POD 1, every mg/L1.000.98--1.020.946  WBC on POD 1 \> 13.78 × 10^3^/μL13.244.59--38.18\< 0.001Multivariate  Diabetes mellitus type 23.131.04--9.480.043  WBC on POD 1 \> 13.78 × 10^3^/μL13.144.50--38.41\< 0.001*OR*, odds ratio; *95% CI*, 95% confidence interval; *BMI*, body mass index; *CRP*, C-reactive protein; *WBC*, white blood count; *POD*, postoperative day

In case of perioperative morbidity of III--V Clavien--Dindo grades, the only significant parameter in univariate logistic regression models was WBC on POD1 \> 13.78 × 103/μL (Table [7](#Tab7){ref-type="table"}).Table 7Logistic regression models of risk factors for perioperative morbidity of III--V Clavien--Dindo after bypassesOR95% CI*p* valueUnivariate  Females0.630.20--1.970.419  Age, every year0.960.91--1.020.165  BMI, every kg/m^2^1.010.64--1.090.788  Diabetes mellitus type 20.450.14--1.500.193  Arterial hypertension1.680.51--5.590.394  Obstructive sleep apnea0.430.05--3.520.425  Operative time, every min1.000.99--1.010.635  WBC on POD 1 \> 13.78 × 10^3^/μL12.53.31--47.16\< 0.001Multivariate*OR*, odds ratio; *95% CI*, 95% confidence interval; *BMI*, body mass index; *CRP*, C-reactive protein; *WBC*, white blood count; *POD*, postoperative day

Discussion {#Sec9}
==========

Bariatric procedures are now considered standard in general surgery in Poland. Moreover, these procedures are performed in low-volume centers and private facilities, often as a single-day admission or as medical tourism. Therefore, identifying early markers predicting perioperative morbidity is needed and relevant, as the patients are usually discharged from hospital at POD 2. We found similar research and study protocols for early markers of morbidity in other fields of general surgery, particularly in colorectal surgery, but we found no studies with a large patient cohort undergoing bariatric surgery analyzing the usefulness of CRP and WBC to predict the risk of perioperative complications, as in our study.

We evaluated patients undergoing surgery for morbid obesity in accordance with the ERAS® protocols \[[@CR12]\]. Our patient groups were similar regarding their baseline characteristics, and our results showed that CRP and WBC values differed between patients who developed complications and those who did not. Multivariate analysis and ROC analysis showed that CRP \> 33.32 mg/L on POD 1 was associated with a three times greater risk of developing complications, and that WBC \> 12.15 × 10^3^/μL on POD 1 was associated with a two times greater risk in patients undergoing LSG. The only inflammatory marker that was significantly associated with a higher risk of morbidity after gastric bypass was WBC \> 13.78 × 10^3^/μL on POD 1, which increased the risk by 13 times. In case of perioperative morbidity of III--V Clavien--Dindo grades, WBC on POD 1 remained indicative risk factor for perioperative morbidity after LSG, as well as bypasses.

Albanopoulos et al., in their study evaluating LSG, showed that WBC and CRP were correlated with leakage or abscess on PODs 3, 5, 7, 9, and 11 \[[@CR6]\]. However, the main disadvantage of the study was the low number of patients with complications, which rendered the conclusions difficult to interpret. Mickevicius et al. presented results after LRYGB and showed that CRP differed significantly on POD 1 between patients with and without postoperative 30-day morbidity. This finding differs from our results regarding LRYGB, which indicated that differences in CRP levels were non-significant \[[@CR14]\]. Villard et al. identified CRP as a specific marker, however, with very low sensitivity \[[@CR15]\]. In their study, the authors identified CRP of 50 mg/L as a predictor of complications. In contrast, our multivariate analysis predicted complications when CRP was \> 33.32 mg/L. The main advantage in our analysis is that our regression models included additional factors. Williams et al. reported even higher CRP levels at \> 90 mg/L on POD 1 in patients with complications and 75 mg/L in patients without complications. Warschkow et al. suggested that CRP should be routinely measured on POD 2 after LRYGB to exclude complications, and leaks in particular \[[@CR16]\]. The authors concluded that radiological imaging examinations for intestinal leaks could be restricted to patients with serum CRP \> 229 mg/L on POD 2. Accordingly, it is difficult to determine the exact cut-off point for CRP concentration to predict complications.

WBC count in a study by Mickevicius et al. did not differ between the groups. Similar results were presented by Ruiz-Tovar et al. \[[@CR17]\], and a study by Da Silva et al. evaluated the correlation between neutrophil-to-lymphocyte ratio (NLR) on POD 1 as a predictive factor for perioperative complications \[[@CR18]\]. Da Silva et al.'s study was a retrospective cohort study of 737 patients who underwent predominantly LRYGB, but also LSG. The authors reported that NLR ≥ 10 on POD 1 was associated with the following 30-day clinical outcomes: prolonged hospital stay (\> 2 days); higher incidence of overall complications and major complications as well as higher readmission rate; and higher reoperation rate. On multivariable analysis, elevated NLR retained its predictive value for all outcome variables, except for readmissions.

Interestingly, prolonged operative time was a significant predictor for perioperative morbidity in patients undergoing LSG, in our study. We believe that this finding was not a result of longer operation times, but, rather, was secondary to technical difficulties or intraoperative adverse events, which we did not analyze in this study \[[@CR4], [@CR19]\]. Major et al. evaluated morbidity after LSG and reported that prolonged operation and increased number of stapler firings were associated with a higher risk of perioperative complications, but interestingly, intraoperative adverse events were not directly associated with an increased risk of perioperative morbidity. In another study by Major et al., decreased oral fluid intake, the need for increased intravenous fluids on the day of surgery, and longer distance from the patient's habitual residence to the bariatric center were potential risk factors for prolonged hospital stay. Intraoperative adverse events also increased the risk for hospital readmission \[[@CR4], [@CR19]\].

In patients undergoing colorectal surgery, measuring inflammatory markers is now almost a routine. However, colorectal surgery has different specificity and higher rates for postoperative morbidity, and leaks are more prevalent, which determines different cut-off points. In a meta-analysis by Cousin et al. of the accuracy of CRP on POD 3 to diagnose intra-abdominal infection after elective colorectal surgery, the cut-offs varied in the studies, from 130 to 190 mg/L \[[@CR20]\]. CRP and procalcitonin were significantly higher much earlier than when patients became symptomatic, at between POD 7 and POD 9 \[[@CR21]--[@CR23]\]. This finding is crucial to understand why we performed a similar study in bariatric surgery. Significantly higher CRP levels were found after colorectal surgery as early as POD 1 in patients who later developed intra-abdominal infection, which raises doubts regarding opinions that anastomotic leakage occurs near POD 7 \[[@CR20], [@CR22], [@CR24]\]. A stronger inflammatory response may be both the consequence and the cause of intra-abdominal infection (impaired healing or reflecting ongoing tissue hypoxia leading to anastomotic leakage) \[[@CR21], [@CR25]\].

The main advantage of our study is the high patient numbers, which makes our conclusions more reliable. We found no ERAS® guidelines indicating laboratory measurements predicting postoperative morbidity. It would be useful to have cut-off points for laboratory measurements of inflammatory markers to select patients requiring longer postoperative stays, for early detection and prevention of postoperative morbidity. Short hospital stays are necessary to maintain a high bariatric surgical volume; therefore, having laboratory criteria for early and safe discharge from hospital would be highly beneficial \[[@CR26]\].

Limitations {#Sec10}
-----------

This was a non-randomized analysis, and our groups were demographically heterogeneous and differed regarding the preoperative factors. Furthermore, because the data were collected separately from seven bariatric centers using different electronic systems, some necessary information was lacking in our initial population, which caused exclusions. After excluding incomplete records and repetitions in the collective database, we obtained our final number of patients, which added selection bias. Additionally, we did not record postoperative events, such as readmissions occurring outside the indexed hospitals. Patients during hospital discharge were informed to report to index hospital in case of any emergencies. In case of patients that live in a long distance they could refer to local hospitals.

Conclusion {#Sec11}
==========

CRP \> 33.32 mg/L and WBC \> 12.15 × 10^3^/μL on POD 1 were associated with a greater risk of developing complications in patients undergoing LSG. WBC \> 13.78 × 10^3^/μL was associated with a higher risk of morbidity in patients after bypass surgery. Even slightly elevated CRP and WBC on POD 1 should alert surgeons to the potential risk of perioperative morbidity.
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